ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orally Disintegrating Tablet Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-14V9021
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Orally Disintegrating Tablet Market Outlook 2022
BUY CHAPTERS

Global Orally Disintegrating Tablet Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-14V9021
Report
June 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Mylan NV
GSK
Otsuka
Astrazeneca plc
Bristol–Myers Squibb
Conquer
Eli Lilly and Company
Johnson and Johnson
TEVA
Pfizer Inc

Orally Disintegrating Tablet Market Size

In 2024, the global market size of Orally Disintegrating Tablet was estimated to be worth US$ 17300 million and is forecast to reach approximately US$ 37140 million by 2031 with a CAGR of 11.7% during the forecast period 2025-2031.

Orally Disintegrating Tablet Market

Orally Disintegrating Tablet Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet.
The Orally Disintegrating Tablet market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Orally Disintegrating Tablet Market Report

Report Metric Details
Report Name Orally Disintegrating Tablet Market
CAGR 11.7%
Segment by Type
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
Segment by Application
  • CNS Diseases
  • Gastrointestinal Diseases
  • CVS Diseases
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Orally Disintegrating Tablet in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Orally Disintegrating Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orally Disintegrating Tablet sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol Myers Squibb, Conquer share in Orally Disintegrating Tablet Market?

Ans: Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market.

What is the Orally Disintegrating Tablet Market share by region?

Ans: North America is the largest market of glass packaging, holding a share more than 40%.

What is the Orally Disintegrating Tablet Market share by application?

Ans: The most common application is in CNS diseases packaging, with a share about 55%.

Who are the main players in the Orally Disintegrating Tablet Market report?

Ans: The main players in the Orally Disintegrating Tablet Market are Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer

What are the Application segmentation covered in the Orally Disintegrating Tablet Market report?

Ans: The Applications covered in the Orally Disintegrating Tablet Market report are CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Others

What are the Type segmentation covered in the Orally Disintegrating Tablet Market report?

Ans: The Types covered in the Orally Disintegrating Tablet Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Others

1 Study Coverage
1.1 Orally Disintegrating Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Orally Disintegrating Tablet Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Orally Disintegrating Tablet Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Market Size Estimates and Forecasts
2.1.1 Global Orally Disintegrating Tablet Revenue 2020-2031
2.1.2 Global Orally Disintegrating Tablet Sales 2020-2031
2.2 Orally Disintegrating Tablet Market Size by Region: 2024 Versus 2031
2.3 Orally Disintegrating Tablet Sales by Region (2020-2031)
2.3.1 Global Orally Disintegrating Tablet Sales by Region: 2020-2025
2.3.2 Global Orally Disintegrating Tablet Sales Forecast by Region (2026-2031)
2.3.3 Global Orally Disintegrating Tablet Sales Market Share by Region (2020-2031)
2.4 Orally Disintegrating Tablet Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Orally Disintegrating Tablet Revenue by Region: 2020-2025
2.4.2 Global Orally Disintegrating Tablet Revenue Forecast by Region (2026-2031)
2.4.3 Global Orally Disintegrating Tablet Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Orally Disintegrating Tablet Sales by Type (2020-2031)
3.1.1.1 Global Orally Disintegrating Tablet Sales Volume by Type (2020-2031)
3.1.1.2 Global Orally Disintegrating Tablet Sales Market Share by Type (2020-2031)
3.1.2 Global Orally Disintegrating Tablet Revenue by Type (2020-2031)
3.1.2.1 Global Orally Disintegrating Tablet Revenue by Type (2020-2031)
3.1.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Type (2020-2031)
3.1.3 Orally Disintegrating Tablet Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Orally Disintegrating Tablet Sales by Application (2020-2031)
3.2.1.1 Global Orally Disintegrating Tablet Sales Volume by Application (2020-2031)
3.2.1.2 Global Orally Disintegrating Tablet Sales Market Share by Application (2020-2031)
3.2.2 Global Orally Disintegrating Tablet Revenue by Application (2020-2031)
3.2.2.1 Global Orally Disintegrating Tablet Revenue by Application (2020-2031)
3.2.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Application (2020-2031)
3.2.3 Orally Disintegrating Tablet Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Anti-Psychotics Drug of Orally Disintegrating Tablet Revenue Market Share by Application
3.3.2 Anti-Epileptics Drug of Orally Disintegrating Tablet Revenue Market Share by Application
3.3.3 Others of Orally Disintegrating Tablet Revenue Market Share by Application
4 Global Orally Disintegrating Tablet by Manufacturers
4.1 Global Top Orally Disintegrating Tablet Manufacturers by Sales (2020-2025)
4.1.1 Global Orally Disintegrating Tablet Sales by Manufacturer (2020-2025)
4.1.2 Global Orally Disintegrating Tablet Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Orally Disintegrating Tablet Manufacturers by Revenue (2020-2025)
4.2.1 Global Orally Disintegrating Tablet Revenue by Manufacturer (2020-2025)
4.2.2 Global Orally Disintegrating Tablet Revenue Share by Manufacturer (2020-2025)
4.3 Global Orally Disintegrating Tablet Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Orally Disintegrating Tablet Manufacturers Covered: Ranking by Revenue
4.4.2 Global Orally Disintegrating Tablet Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Orally Disintegrating Tablet Manufacturing Base Distribution, Product Type
4.5.1 Orally Disintegrating Tablet Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Orally Disintegrating Tablet Market
4.5.3 Manufacturers Orally Disintegrating Tablet Product Type and Application
4.5.4 Anti-Psychotics Drug Market Sales of Orally Disintegrating Tablet by Manufacturer
4.5.5 Anti-Epileptics Drug Market Sales of Orally Disintegrating Tablet by Manufacturer
4.5.6 Others Market Sales of Orally Disintegrating Tablet by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Teva
5.1.1 Teva Company Information
5.1.2 Teva Description, Business Overview
5.1.3 Teva Orally Disintegrating Tablet Products Offered
5.1.4 Teva Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Teva Orally Disintegrating Tablet Sales by Product in 2024
5.1.6 Teva Orally Disintegrating Tablet Sales by Application in 2024
5.1.7 Teva Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.1.8 Teva Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Orally Disintegrating Tablet Products Offered
5.2.4 Merck Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Orally Disintegrating Tablet Sales by Product in 2024
5.2.6 Merck Orally Disintegrating Tablet Sales by Application in 2024
5.2.7 Merck Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Mylan
5.3.1 Mylan Company Information
5.3.2 Mylan Description, Business Overview
5.3.3 Mylan Orally Disintegrating Tablet Products Offered
5.3.4 Mylan Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Mylan Orally Disintegrating Tablet Sales by Product in 2024
5.3.6 Mylan Orally Disintegrating Tablet Sales by Application in 2024
5.3.7 Mylan Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.3.8 Mylan Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Orally Disintegrating Tablet Products Offered
5.4.4 Pfizer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Orally Disintegrating Tablet Sales by Product in 2024
5.4.6 Pfizer Orally Disintegrating Tablet Sales by Application in 2024
5.4.7 Pfizer Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Johnson and Johnson
5.5.1 Johnson and Johnson Company Information
5.5.2 Johnson and Johnson Description, Business Overview
5.5.3 Johnson and Johnson Orally Disintegrating Tablet Products Offered
5.5.4 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Johnson and Johnson Orally Disintegrating Tablet Sales by Product in 2024
5.5.6 Johnson and Johnson Orally Disintegrating Tablet Sales by Application in 2024
5.5.7 Johnson and Johnson Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.5.8 Johnson and Johnson Recent Developments
5.6 GSK
5.6.1 GSK Company Information
5.6.2 GSK Description, Business Overview
5.6.3 GSK Orally Disintegrating Tablet Products Offered
5.6.4 GSK Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.6.5 GSK Orally Disintegrating Tablet Sales by Product in 2024
5.6.6 GSK Orally Disintegrating Tablet Sales by Application in 2024
5.6.7 GSK Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.6.8 GSK Recent Developments
5.7 Otsuka
5.7.1 Otsuka Company Information
5.7.2 Otsuka Description, Business Overview
5.7.3 Otsuka Orally Disintegrating Tablet Products Offered
5.7.4 Otsuka Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Otsuka Orally Disintegrating Tablet Sales by Product in 2024
5.7.6 Otsuka Orally Disintegrating Tablet Sales by Application in 2024
5.7.7 Otsuka Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.7.8 Otsuka Recent Developments
5.8 Eli Lilly and Company
5.8.1 Eli Lilly and Company Company Information
5.8.2 Eli Lilly and Company Description, Business Overview
5.8.3 Eli Lilly and Company Orally Disintegrating Tablet Products Offered
5.8.4 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Eli Lilly and Company Orally Disintegrating Tablet Sales by Product in 2024
5.8.6 Eli Lilly and Company Orally Disintegrating Tablet Sales by Application in 2024
5.8.7 Eli Lilly and Company Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.8.8 Eli Lilly and Company Recent Developments
5.9 AstraZeneca
5.9.1 AstraZeneca Company Information
5.9.2 AstraZeneca Description, Business Overview
5.9.3 AstraZeneca Orally Disintegrating Tablet Products Offered
5.9.4 AstraZeneca Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.9.5 AstraZeneca Orally Disintegrating Tablet Sales by Product in 2024
5.9.6 AstraZeneca Orally Disintegrating Tablet Sales by Application in 2024
5.9.7 AstraZeneca Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.9.8 AstraZeneca Recent Developments
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Company Information
5.10.2 Bristol-Myers Squibb Description, Business Overview
5.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Products Offered
5.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Bristol-Myers Squibb Orally Disintegrating Tablet Sales by Product in 2024
5.10.6 Bristol-Myers Squibb Orally Disintegrating Tablet Sales by Application in 2024
5.10.7 Bristol-Myers Squibb Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.10.8 Bristol-Myers Squibb Recent Developments
5.11 Conquer
5.11.1 Conquer Company Information
5.11.2 Conquer Description, Business Overview
5.11.3 Conquer Orally Disintegrating Tablet Products Offered
5.11.4 Conquer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Conquer Orally Disintegrating Tablet Sales by Product in 2024
5.11.6 Conquer Orally Disintegrating Tablet Sales by Application in 2024
5.11.7 Conquer Orally Disintegrating Tablet Sales by Geographic Area in 2024
5.11.8 Conquer Recent Developments
6 North America
6.1 North America Orally Disintegrating Tablet Market Size YoY Growth 2020-2031
6.2 North America Orally Disintegrating Tablet Market Facts & Figures by Country
6.2.1 North America Orally Disintegrating Tablet Sales by Country (2020-2031)
6.2.2 North America Orally Disintegrating Tablet Revenue by Country (2020-2031)
6.3 North America Orally Disintegrating Tablet Sales by Type (2020-2025)
6.4 North America Orally Disintegrating Tablet Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Orally Disintegrating Tablet Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Orally Disintegrating Tablet Market Facts & Figures by Region
7.2.1 Asia-Pacific Orally Disintegrating Tablet Sales by Region (2020-2031)
7.2.2 Asia-Pacific Orally Disintegrating Tablet Revenue by Region (2020-2031)
7.3 Asia-Pacific Orally Disintegrating Tablet Sales by Type (2020-2025)
7.4 Asia-Pacific Orally Disintegrating Tablet Sales by Application (2020-2025)
8 Europe
8.1 Europe Orally Disintegrating Tablet Market Size YoY Growth 2020-2031
8.2 Europe Orally Disintegrating Tablet Market Facts & Figures by Country
8.2.1 Europe Orally Disintegrating Tablet Sales by Country (2020-2031)
8.2.2 Europe Orally Disintegrating Tablet Revenue by Country (2020-2031)
8.3 Europe Orally Disintegrating Tablet Sales by Type (2020-2025)
8.4 Europe Orally Disintegrating Tablet Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Orally Disintegrating Tablet Market Size YoY Growth 2020-2031
9.2 Latin America Orally Disintegrating Tablet Market Facts & Figures by Country
9.2.1 Latin America Orally Disintegrating Tablet Sales by Country (2020-2031)
9.2.2 Latin America Orally Disintegrating Tablet Revenue by Country (2020-2031)
9.3 Latin America Orally Disintegrating Tablet Sales by Type (2020-2025)
9.4 Latin America Orally Disintegrating Tablet Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Orally Disintegrating Tablet Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Orally Disintegrating Tablet Market Facts & Figures by Country
10.2.1 Middle East and Africa Orally Disintegrating Tablet Sales by Country (2020-2031)
10.2.2 Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2020-2031)
10.3 Middle East and Africa Orally Disintegrating Tablet Sales by Type (2020-2025)
10.4 Middle East and Africa Orally Disintegrating Tablet Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Orally Disintegrating Tablet Supply Chain Analysis
11.2 Orally Disintegrating Tablet Key Raw Materials and Upstream Suppliers
11.3 Orally Disintegrating Tablet Clients Analysis
11.4 Orally Disintegrating Tablet Sales Channel and Sales Model Analysis
11.4.1 Orally Disintegrating Tablet Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Orally Disintegrating Tablet Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Orally Disintegrating Tablet Distributors
12 Orally Disintegrating Tablet Market Dynamics
12.1 Orally Disintegrating Tablet Industry Trends
12.2 Orally Disintegrating Tablet Market Drivers
12.3 Orally Disintegrating Tablet Market Challenges
12.4 Orally Disintegrating Tablet Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
Mylan NV
GSK
Otsuka
Astrazeneca plc
Bristol–Myers Squibb
Conquer
Eli Lilly and Company
Johnson and Johnson
TEVA
Pfizer Inc
List of Tables
 Table 1. Global Orally Disintegrating Tablet Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Orally Disintegrating Tablet Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Orally Disintegrating Tablet Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Orally Disintegrating Tablet Sales by Region (2020-2025) & (M Units)
 Table 5. Global Orally Disintegrating Tablet Sales Forecast by Region (2026-2031) & (M Units)
 Table 6. Global Orally Disintegrating Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Orally Disintegrating Tablet Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Orally Disintegrating Tablet Sales Volume by Type (2020-2025) & (M Units)
 Table 9. Global Orally Disintegrating Tablet Sales Volume by Type (2026-2031) & (M Units)
 Table 10. Global Orally Disintegrating Tablet Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Orally Disintegrating Tablet Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Orally Disintegrating Tablet Sales Volume by Application (2020-2025) & (M Units)
 Table 13. Global Orally Disintegrating Tablet Sales Volume by Application (2026-2031) & (M Units)
 Table 14. Global Orally Disintegrating Tablet Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Orally Disintegrating Tablet Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Orally Disintegrating Tablet Sales by Manufacturer (2020-2025) & (M Units)
 Table 17. Global Orally Disintegrating Tablet Sales Share by Manufacturer (2020-2025)
 Table 18. Orally Disintegrating Tablet Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Orally Disintegrating Tablet Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Orally Disintegrating Tablet Price (2020-2025) & (US$/Unit)
 Table 21. Ranking of Global Top Orally Disintegrating Tablet Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Orally Disintegrating Tablet Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Orally Disintegrating Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet as of 2024)
 Table 24. Orally Disintegrating Tablet Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Orally Disintegrating Tablet Market
 Table 26. Manufacturers Orally Disintegrating Tablet Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Teva Company Information
 Table 29. Teva Description and Business Overview
 Table 30. Teva Orally Disintegrating Tablet Product
 Table 31. Teva Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 32. Teva Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 33. Teva Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 34. Teva Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 35. Teva Recent Developments
 Table 36. Merck Company Information
 Table 37. Merck Description and Business Overview
 Table 38. Merck Orally Disintegrating Tablet Product
 Table 39. Merck Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 40. Merck Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 41. Merck Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 42. Merck Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 43. Merck Recent Developments
 Table 44. Mylan Company Information
 Table 45. Mylan Description and Business Overview
 Table 46. Mylan Orally Disintegrating Tablet Product
 Table 47. Mylan Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 48. Mylan Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 49. Mylan Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 50. Mylan Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 51. Mylan Recent Developments
 Table 52. Pfizer Company Information
 Table 53. Pfizer Description and Business Overview
 Table 54. Pfizer Orally Disintegrating Tablet Product
 Table 55. Pfizer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 56. Pfizer Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 57. Pfizer Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 58. Pfizer Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 59. Pfizer Recent Developments
 Table 60. Johnson and Johnson Company Information
 Table 61. Johnson and Johnson Description and Business Overview
 Table 62. Johnson and Johnson Orally Disintegrating Tablet Product
 Table 63. Johnson and Johnson Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 64. Johnson and Johnson Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 65. Johnson and Johnson Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 66. Johnson and Johnson Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 67. Johnson and Johnson Recent Developments
 Table 68. GSK Company Information
 Table 69. GSK Description and Business Overview
 Table 70. GSK Orally Disintegrating Tablet Product
 Table 71. GSK Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. GSK Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 73. GSK Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 74. GSK Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 75. GSK Recent Developments
 Table 76. Otsuka Company Information
 Table 77. Otsuka Description and Business Overview
 Table 78. Otsuka Orally Disintegrating Tablet Product
 Table 79. Otsuka Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Otsuka Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 81. Otsuka Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 82. Otsuka Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 83. Otsuka Recent Developments
 Table 84. Eli Lilly and Company Company Information
 Table 85. Eli Lilly and Company Description and Business Overview
 Table 86. Eli Lilly and Company Orally Disintegrating Tablet Product
 Table 87. Eli Lilly and Company Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Eli Lilly and Company Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 89. Eli Lilly and Company Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 90. Eli Lilly and Company Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 91. Eli Lilly and Company Recent Developments
 Table 92. AstraZeneca Company Information
 Table 93. AstraZeneca Description and Business Overview
 Table 94. AstraZeneca Orally Disintegrating Tablet Product
 Table 95. AstraZeneca Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 96. AstraZeneca Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 97. AstraZeneca Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 98. AstraZeneca Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 99. AstraZeneca Recent Developments
 Table 100. Bristol-Myers Squibb Company Information
 Table 101. Bristol-Myers Squibb Description and Business Overview
 Table 102. Bristol-Myers Squibb Orally Disintegrating Tablet Product
 Table 103. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Bristol-Myers Squibb Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 105. Bristol-Myers Squibb Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 106. Bristol-Myers Squibb Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 107. Bristol-Myers Squibb Recent Developments
 Table 108. Conquer Company Information
 Table 109. Conquer Description and Business Overview
 Table 110. Conquer Orally Disintegrating Tablet Product
 Table 111. Conquer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 112. Conquer Sales Proportion of Orally Disintegrating Tablet by Product in 2024
 Table 113. Conquer Sales Proportion of Orally Disintegrating Tablet by Application in 2024
 Table 114. Conquer Sales Proportion of Orally Disintegrating Tablet by Geographic Area in 2024
 Table 115. Conquer Recent Developments
 Table 116. North America Orally Disintegrating Tablet Sales by Country (2020-2025) & (M Units)
 Table 117. North America Orally Disintegrating Tablet Sales by Country (2026-2031) & (M Units)
 Table 118. North America Orally Disintegrating Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 119. North America Orally Disintegrating Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 120. North America Orally Disintegrating Tablet Sales by Type (2020-2025) & (M Units)
 Table 121. North America Orally Disintegrating Tablet Sales by Application (2020-2025) & (M Units)
 Table 122. Asia-Pacific Orally Disintegrating Tablet Sales by Region (2020-2025) & (M Units)
 Table 123. Asia-Pacific Orally Disintegrating Tablet Sales by Region (2026-2031) & (M Units)
 Table 124. Asia-Pacific Orally Disintegrating Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 125. Asia-Pacific Orally Disintegrating Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 126. Asia-Pacific Orally Disintegrating Tablet Sales by Type (2020-2025) & (M Units)
 Table 127. Asia-Pacific Orally Disintegrating Tablet Sales by Application (2020-2025) & (M Units)
 Table 128. Europe Orally Disintegrating Tablet Sales by Country (2020-2025) & (M Units)
 Table 129. Europe Orally Disintegrating Tablet Sales by Country (2026-2031) & (M Units)
 Table 130. Europe Orally Disintegrating Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 131. Europe Orally Disintegrating Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 132. Europe Orally Disintegrating Tablet Sales by Type (2020-2025) & (M Units)
 Table 133. Europe Orally Disintegrating Tablet Sales by Application (2020-2025) & (M Units)
 Table 134. Latin America Orally Disintegrating Tablet Sales by Country (2020-2025) & (M Units)
 Table 135. Latin America Orally Disintegrating Tablet Sales by Country (2026-2031) & (M Units)
 Table 136. Latin America Orally Disintegrating Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 137. Latin America Orally Disintegrating Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 138. Latin America Orally Disintegrating Tablet Sales by Type (2020-2025) & (M Units)
 Table 139. Latin America Orally Disintegrating Tablet Sales by Application (2020-2025) & (M Units)
 Table 140. Middle East and Africa Orally Disintegrating Tablet Sales by Country (2020-2025) & (M Units)
 Table 141. Middle East and Africa Orally Disintegrating Tablet Sales by Country (2026-2031) & (M Units)
 Table 142. Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 143. Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 144. Middle East and Africa Orally Disintegrating Tablet Sales by Type (2020-2025) & (M Units)
 Table 145. Middle East and Africa Orally Disintegrating Tablet Sales by Application (2020-2025) & (M Units)
 Table 146. Orally Disintegrating Tablet Key Raw Materials, Industry Status and Trend
 Table 147. Orally Disintegrating Tablet Key Raw Materials and Upstream Suppliers
 Table 148. Orally Disintegrating Tablet Clients Status and Trend
 Table 149. Orally Disintegrating Tablet Typical Clients
 Table 150. Orally Disintegrating Tablet Distributors
 Table 151. Orally Disintegrating Tablet Market Trends
 Table 152. Orally Disintegrating Tablet Market Drivers
 Table 153. Orally Disintegrating Tablet Market Challenges
 Table 154. Orally Disintegrating Tablet Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Orally Disintegrating Tablet Product Picture
 Figure 2. Global Orally Disintegrating Tablet Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Orally Disintegrating Tablet Sales Market Share by Type in 2024 & 2031
 Figure 4. Anti-Psychotics Drug Product Picture
 Figure 5. Anti-Epileptics Drug Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Orally Disintegrating Tablet Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Orally Disintegrating Tablet Sales Market Share by Application in 2024 & 2031
 Figure 9. CNS Diseases
 Figure 10. Gastrointestinal Diseases
 Figure 11. CVS Diseases
 Figure 12. Others
 Figure 13. Orally Disintegrating Tablet Report Years Considered
 Figure 14. Global Orally Disintegrating Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Orally Disintegrating Tablet Market Size 2020-2031 (US$ Million)
 Figure 16. Global Orally Disintegrating Tablet Sales 2020-2031 (M Units)
 Figure 17. Global Orally Disintegrating Tablet Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Orally Disintegrating Tablet Revenue Market Share by Region (2020-2031)
 Figure 19. Global Orally Disintegrating Tablet Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Orally Disintegrating Tablet Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Orally Disintegrating Tablet Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
 Figure 22. Global Orally Disintegrating Tablet Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Orally Disintegrating Tablet Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Orally Disintegrating Tablet Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
 Figure 25. Anti-Psychotics Drug of Orally Disintegrating Tablet Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Anti-Epileptics Drug of Orally Disintegrating Tablet Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Others of Orally Disintegrating Tablet Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Global Orally Disintegrating Tablet Sales Share by Manufacturer in 2024
 Figure 29. Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 30. Anti-Psychotics Drug Market Sales Proportion by Manufacturer in 2024
 Figure 31. Anti-Epileptics Drug Market Sales Proportion by Manufacturer in 2024
 Figure 32. Others Market Sales Proportion by Manufacturer in 2024
 Figure 33. North America Orally Disintegrating Tablet Revenue 2020-2031 (US$ Million)
 Figure 34. North America Orally Disintegrating Tablet Sales Market Share by Type (2020-2025)
 Figure 35. North America Orally Disintegrating Tablet Sales Market Share by Application (2020-2025)
 Figure 36. Asia-Pacific Orally Disintegrating Tablet Revenue 2020-2031 (US$ Million)
 Figure 37. Asia-Pacific Orally Disintegrating Tablet Sales Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Orally Disintegrating Tablet Revenue Market Share by Region (2020-2031)
 Figure 39. Asia-Pacific Orally Disintegrating Tablet Sales Market Share by Type (2020-2025)
 Figure 40. Asia-Pacific Orally Disintegrating Tablet Sales Market Share by Application (2020-2025)
 Figure 41. Europe Orally Disintegrating Tablet Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Europe Orally Disintegrating Tablet Sales Market Share by Country (2020-2031)
 Figure 43. Europe Orally Disintegrating Tablet Revenue Market Share by Country (2020-2031)
 Figure 44. Europe Orally Disintegrating Tablet Sales Market Share by Type (2020-2025)
 Figure 45. Europe Orally Disintegrating Tablet Sales Market Share by Application (2020-2025)
 Figure 46. Latin America Orally Disintegrating Tablet Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Latin America Orally Disintegrating Tablet Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Orally Disintegrating Tablet Revenue Market Share by Country (2020-2025)
 Figure 49. Latin America Orally Disintegrating Tablet Sales Market Share by Type (2020-2025)
 Figure 50. Latin America Orally Disintegrating Tablet Sales Market Share by Application (2020-2025)
 Figure 51. Middle East and Africa Orally Disintegrating Tablet Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 52. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Orally Disintegrating Tablet Revenue Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Type (2020-2025)
 Figure 55. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Application (2020-2025)
 Figure 56. Orally Disintegrating Tablet Supply Chain (Upstream and Downstream Market)
 Figure 57. Global Production Market Share of Orally Disintegrating Tablet Raw Materials by Region in 2024
 Figure 58. Orally Disintegrating Tablet Distribution Channels
 Figure 59. Global Orally Disintegrating Tablet Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 60. Global Orally Disintegrating Tablet Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Orally Disintegrating Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Orally Disintegrating Tablets Market Research Report 2024
Global Orally Disintegrating Tablet Excipient Market Insights Forecast to 2030
Orally Dissolving Tablets ODT Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mouth dissolving Tablets Market Insights Forecast to 2030
Global Fast disintegrating Tablets Market Insights Forecast to 2030
Global Rapid dissolving Tablets Market Insights Forecast to 2030
Global Fast dissolving Tablets Market Insights Forecast to 2030
Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024
Global Orally Disintegrating Tablet Technology Market Research Report 2024
Global Orodispersible Tablets Market Insights Forecast to 2030
Global Excipients for Orally Disintegrating Tablets ODT Market Research Report 2024
Global Oral Disintegrating Strips Market Research Report 2024
Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024
Global Oral Solid Dosage Medicine Market Research Report 2025
Global Oral Fast Dissolving Film OFDF Market Research Report 2024
Global Aripiprazole Orally Disintegrating Tablets ODT Market Research Report 2025
Global Orodispersible Film Market Research Report 2025
Global Fast Melt Tablet Market Research Report 2024
Global Orally Disintegrating Films ODFs Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions